Mj. Thun et al., CIGARETTE-SMOKING AND CHANGES IN THE HISTOPATHOLOGY OF LUNG-CANCER, Journal of the National Cancer Institute, 89(21), 1997, pp. 1580-1586
Background: Adenocarcinoma of the lung, once considered minimally rela
ted to cigarette smoking, has become the most common type of lung canc
er in the United States, The increased incidence of this cancer might
be explained by advances in diagnostic technology (i.e., increased abi
lity to perform biopsies on tumors in smaller, more distal airways), c
hanges in cigarette design (e.g., the adoption of filtertips), or chan
ges in smoking practices, We examined data from the Connecticut Tumor
Registry and two American Cancer Society studies to explore these poss
ibilities, Methods: Connecticut Tumor Registry data from 1959 through
1991 were analyzed to determine whether the increase in lung adenocarc
inoma observed during that period could be best described by birth coh
ort effects (i.e., generational changes in cigarette smoking) or calen
dar period effects (i.e., diagnostic advances), Associations between c
igarette smoking and death from specific types of lung cancer during t
he first 2 years of follow-up in Cancer Prevention Study I (CPS-I), in
itiated in 1959) and Cancer Prevention Study II (CPS-II, initiated in
1982) were also examined, Results: Adenocarcinoma incidence in Connect
icut increased nearly 17-fold in women and nearly 10-fold in men from
1959 through 1991, The increases followed a clear birth cohort pattern
, paralleling gender and generational changes in smoking more than dia
gnostic advances, Cigarette smoking became more strongly associated wi
th death from lung adenocarcinoma in CPS-II compared with CPS-I, with
relative risks of 19.0 (95% confidence interval [CI] = 8.3-47.7) for m
en and 8.1 (95% CI = 4.5-14.6) for women in CPS-II and 4.6 (95% CI 1.7
-12.6) for men and 1.5 (0.3-7.7) for women in CPS-I, Conclusions: The
increase in lung adenocarcinoma since the 1950s is more consistent wit
h changes in smoking behavior and cigarette design than with diagnosti
c advances.